Stocklytics Platform
Asset logo for symbol SYK
Stryker
SYK74
$364.60arrow_drop_up2.06%$7.36
High Quality
S&P500
Asset logo for symbol SYK
SYK74

$364.60

arrow_drop_up2.06%

Performance History

Chart placeholder
Key Stats
Open$356.23
Prev. Close$357.14
EPS9.52
Next Earnings DateJan 31, 2025
LOWHIGH
Day Range356.02
370.99
52 Week Range249.98
398.94
Ratios
EPS9.52

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Stryker (SYK)

Stryker Corporation is a leading medical technology company that specializes in orthopedic implants, surgical instruments, and medical devices. The company was founded in 1941 and is headquartered in Michigan, United States. With a strong focus on innovation and cutting-edge technology, Stryker Corp has established itself as a key player in the healthcare industry.
Stryker Corp has a rich history of delivering innovative solutions to improve patient outcomes. The company's products are used in a wide range of medical procedures, including joint replacement surgeries, spinal surgeries, and trauma cases. By providing surgeons with advanced tools and implants, Stryker Corp aims to enhance the quality of care and make a positive impact on patients' lives.
In recent years, Stryker Corp has experienced steady growth and has consistently outperformed its competitors. The company's stock price has seen a significant increase, reflecting the market's confidence in its ability to deliver strong financial results. Stryker Corp's market capitalization stands at over $100 billion, making it one of the largest medical technology companies in the world.
One of the key factors driving Stryker Corp's success is its focus on research and development. The company invests heavily in R&D to develop innovative products that address unmet medical needs. By staying at the forefront of technological advancements, Stryker Corp is able to maintain a competitive edge in the industry.
Stryker Corp also stands out for its commitment to sustainability and corporate social responsibility. The company has implemented various initiatives to reduce its environmental footprint and promote social well-being. Stryker Corp has been recognized for its efforts, receiving numerous awards and accolades for its sustainability practices.
Looking ahead, Stryker Corp is well-positioned to capitalize on new opportunities in the healthcare industry. The company's strong financial position, coupled with its focus on innovation, puts it in a prime position to drive growth and deliver value to its shareholders. As the demand for advanced medical technology continues to rise, Stryker Corp remains committed to improving patient outcomes and transforming healthcare.
Stryker Corp, SYK stock performance has been solid, consistently exceeding market expectations. The company's stock price has been on an upward trajectory, reflecting investors' confidence in its ability to deliver strong financial results. Stryker Corp's success can be attributed to several factors, including its robust product portfolio, focus on innovation, and strategic acquisitions.
Stryker Corp's stock price history shows steady growth over the years, with occasional fluctuations in response to market conditions. The company's strategic acquisitions have played a significant role in its growth strategy, allowing it to expand its product offerings and reach new markets. By acquiring companies that complement its existing portfolio, Stryker Corp has been able to enhance its competitive position and capture new market opportunities.
Stryker Corp's financial performance has also been impressive. The company has consistently delivered strong revenue and earnings growth, outperforming its industry peers. This is reflected in its PEG ratio, which measures the company's valuation relative to its expected earnings growth. With a PEG ratio below 1, Stryker Corp is considered undervalued, suggesting that there is potential for further upside in its stock price.
In terms of its market cap, Stryker Corp is one of the largest medical technology companies in the world. Its market cap exceeds $100 billion, reflecting its strong position in the healthcare industry. The company's market cap is a testament to its ability to generate significant shareholder value and its potential for future growth.
Compared to its industry peers, Stryker Corp has consistently outperformed. The company's strong financial performance, coupled with its focus on innovation and customer-centric approach, has helped it gain a competitive edge. Stryker Corp's products are known for their quality, reliability, and innovation, making it the preferred choice for surgeons and healthcare providers.
Stryker Corp's 52-week range reflects the highest and lowest prices at which its stock has traded over the past year. The company's stock price has shown resilience, even during periods of market volatility. This is a testament to the market's confidence in Stryker Corp's ability to deliver consistent financial results and drive long-term value for its shareholders.
The day range for Stryker Corp's stock represents the highest and lowest prices at which it has traded during a single trading day. The day range can fluctuate based on various factors, including market conditions, investor sentiment, and company-specific news. By closely monitoring the day range, investors can gain insights into short-term price movements and make informed trading decisions.
As for trading volume, it represents the number of shares traded in a given period. Higher trading volume is generally considered a positive sign, indicating increased investor interest and liquidity. Stryker Corp's trading volume has consistently been relatively high, reflecting the market's active participation and interest in the company's stock.
Websitecall_made
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Kevin A. Lobo
Headquarters
Kalamazoo
Employees
51000
Exchange
NYSE
add Stryker to watchlist

Keep an eye on Stryker

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Stryker's (SYK) price per share?

The current price per share for Stryker (SYK) is $364.6. The stock has seen a price change of $7.36 recently, indicating a 2.06% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Stryker (SYK)?

For Stryker (SYK), the 52-week high is $398.95, which is 9.42% from the current price. The 52-week low is $249.98, the current price is 45.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Stryker (SYK) a growth stock?

Stryker (SYK) has shown an average price growth of -4.38% over the past three years. It has received a score of 67 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Stryker as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Stryker (SYK) stock price performance year to date (YTD)?

As of the latest data, Stryker (SYK) has a year-to-date price change of 23.08%. Over the past month, the stock has experienced a price change of -6.55%. Over the last three months, the change has been -0.53%. Over the past six months, the figure is 6.41%. Looking at a longer horizon, the five-year price change stands at 71.54%.
help

Is Stryker (SYK) a profitable company?

Stryker (SYK) has a net income of $3.16B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 63.89% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 21.59% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $20.5B, with a revenue growth rate of 11.11%, providing insight into the company's sales performance and growth. The gross profit is $13.1B. Operating income is noted at $3.89B. Furthermore, the EBITDA is $5.41B.
help

What is the market capitalization of Stryker (SYK)?

Stryker (SYK) has a market capitalization of $138.99B. The average daily trading volume is 363.06, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level